Related content

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial

By Emaus N.   Gjesdal C.   Almås B.   Christensen M.   Grimsgaard A.   Berntsen G.   Salomonsen L.   Fønnebø V.  

Osteoporosis International, Vol. 21, Iss. 10, 2010-10 ,pp. : 1731-1740

Springer Publishing Company

Access to resources Recommend Favorite

Phase II, randomised, double‐blind, placebo‐controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH‐agonist therapy

By  

BJU INTERNATIONAL, Vol. 1464-4096, Iss. 5, 2015-11 ,pp. : 744-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II, randomised, double‐blind, placebo‐controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH‐agonist therapy

By  

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 744-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corticosteroid injection in patients with ulnar neuropathy at the elbow: A randomized, double‐blind, placebo‐controlled trial

By  

MUSCLE AND NERVE, Vol. 52, Iss. 3, 2015-09 ,pp. : 380-385

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

By Bhattoa H.   Bettembuk P.   Balogh A.   Szegedi G.   Kiss E.  

Osteoporosis International, Vol. 15, Iss. 5, 2004-05 ,pp. : 396-404

Springer Publishing Company

Access to resources Recommend Favorite